ATC code C
ATC code C Cardiovascular system is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QC...[2]National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
| C Cardiovascular system | |||
|---|---|---|---|
| C01 Cardiac therapy | |||
| C02 Antihypertensives | |||
| C03 Diuretics | |||
| C04 Peripheral vasodilators | |||
| C05 Vasoprotectives | |||
| C07 Beta blocking agents | |||
| C08 Calcium channel blockers | |||
| C09 Agents acting on the renin-angiotensin system | |||
| C10 Lipid modifying agents | |||
|
| |||
References
- ↑ "ATC/DDD Index 2016: code C". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2016: code QC". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia - version of the Monday, February 25, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.